EUVIMEDEUVIMED entdecken
Crossref

Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia

Rouba Sayegh iD, Li Tang, Ki Wook Yun, Zhaohui Xu, Sarah A Marzec, Osama El-Assal, Amy L Leber, Kathy Everhart, Sara Mertz, Ankita Desai, Daniel M Cohen, Sherman J Alter und 8 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Rouba Sayegh und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital. Hauptthemen laut MEDLINE: Community-Acquired Infections, Cytokines, Nasal Mucosa, Pneumonia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: BioFire Diagnostics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in children. Assessing disease severity and etiology remains challenging in the clinical setting. The objective of this study was to identify mucosal biomarkers that could potentially assist with patient classification.

Methods

We analyzed mucosal concentrations of cytokines in nasopharyngeal samples obtained from a convenience sample of 182 children with CAP and 26 matched healthy controls. Pathogens were identified by cultures and molecular assays. Severe disease was defined by hospital stay ≥3 days and/or pediatric intensive care unit admission. Data were analyzed according to identified pathogens and disease severity.

Results

Children with CAP and detected atypical bacteria had significantly higher concentrations of monocyte chemotactic protein 2 (MCP-2), interferon gamma (IFN-γ), and CXCL10, among others, compared with those with typical bacteria. Children with influenza virus had significantly higher concentrations of MCP-2, CXCL10, CXCL11, CX3CL1, and IFN-γ than those with typical bacteria. Additionally, children with severe CAP had significantly higher concentrations of CCL23 than children with mild/moderate disease, irrespective of the pathogen(s) identified.

Conclusions

We identified differences in mucosal concentrations of inflammatory and antiviral cytokines in children with CAP according to disease severity and detected pathogens. Mucosal biomarkers represent a promising approach to help assess disease severity and etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsCytokinesNasal MucosaPneumoniaHumansBiomarkersFemaleMaleChild, PreschoolSeverity of Illness IndexChildInfantCase-Control StudiesChemokine CXCL10Community-Acquired Pneumonia

Stichwörter der Autor:innen

childrencommunity-acquired pneumoniacytokinesnasal mucosarespiratory viruses

Substanzen

BiomarkersCytokinesChemokine CXCL10

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital.
  • Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
  • Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
  • Division of Hospital Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus.
  • Department of Pediatrics, Akron Children's Hospital, Akron.

ORCID-Profile: Rouba Sayegh, Asuncion Mejias, Octavio Ramilo

Förderung

  • BioFire Diagnostics

Zitieren

APA

Sayegh, R., Tang, L., Yun, K. W., Xu, Z., Marzec, S. A., El-Assal, O., Leber, A. L., Everhart, K., Mertz, S., Desai, A., Cohen, D. M., Alter, S. J., Ambroggio, L., Florin, T. A., Keaton, M., Shah, S. S., Ruddy, R. M., Wallihan, R., Mejias, A., & Ramilo, O. (2025). Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae465

Vancouver

Sayegh R, Tang L, Yun KW, Xu Z, Marzec SA, El-Assal O, et al. Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae465

BibTeX
@article{Sayegh2025,
  author = {Sayegh, Rouba and Tang, Li and Yun, Ki Wook and Xu, Zhaohui and Marzec, Sarah A and El-Assal, Osama and Leber, Amy L and Everhart, Kathy and Mertz, Sara and Desai, Ankita and Cohen, Daniel M and Alter, Sherman J and Ambroggio, Lilliam and Florin, Todd A and Keaton, Meghan and Shah, Samir S and Ruddy, Richard M and Wallihan, Rebecca and Mejias, Asuncion and Ramilo, Octavio},
  title = {Nasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae465}
}
Kostenlos starten →